Category & trade
Primary
diabetes · embed-ft 0.54
Tree path
Medical Health › Diseases and Conditions › Diabetes
Group (tier-1)
Tech stack
AI readiness
AI-Readiness score
42 / 100 · partial · see similar
AI training policy
allowed
Terms of Service
AI-bot protection
AI files
llms.txt ai.txt humans.txt robots.txt
Compliance (GEO / GDPR)
TLD
Overview
Title
TZIELDHCP.com | For US Healthcare Providers
Description
TZIELD® (teplizumab-mzwv) is indicated to delay the onset of Stage 3 Type 1 Diabetes (T1D) in adults and children 1 year of age and older who have Stage 2 T1D and to delay the decline in insulin produced by the body in children 8 to 17 years of age who were recently diagnosed with Stage 3 T1D. Please see full Prescribing Information, including Boxed WARNING.
Final URL
Language
en (html)
Scanned at
2026-07-13 21:10:11